International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study.
- DOI
- 10.1016/s1470-2045(26)00089-6
- Published
- 2026 Jun
- Container
- The Lancet. Oncology
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s1470-2045-26-00089-6,
title = {International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study.},
author = {Morgan E and Bardot A and Langselius O and Rutherford MJ and Elkader HA and Bennett D and Brennan A and Bucher O and Butler J and Cameron DA and Canfell K and Chiam K and Chiarelli A and Creighton N and De P and Evans S and Fitzpatrick D and Guren MG and Hannah J and Huws DW and Jackson CGCA and Kønig SM and Kumar E and Larønningen S and Lawler M and Liu Q and McClure C and Mehmood A and Mitchell H and Morrison DS and Murray D and Norwood T and Phillips KAM and Ransom D and Shack L and Smits S and Saint-Jacques N and Marvelde LT and Tran D and Turner D and Ursin G and Vernon S and Walker MJ and Woods RR and Zhang B and Bray F and Soerjomataram I},
year = {2026},
journal = {The Lancet. Oncology},
doi = {10.1016/s1470-2045(26)00089-6},
url = {https://doi.org/10.1016/s1470-2045(26)00089-6}
}RIS
TY - JOUR TI - International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study. AU - Morgan E AU - Bardot A AU - Langselius O AU - Rutherford MJ AU - Elkader HA AU - Bennett D AU - Brennan A AU - Bucher O AU - Butler J AU - Cameron DA AU - Canfell K AU - Chiam K AU - Chiarelli A AU - Creighton N AU - De P AU - Evans S AU - Fitzpatrick D AU - Guren MG AU - Hannah J AU - Huws DW AU - Jackson CGCA AU - Kønig SM AU - Kumar E AU - Larønningen S AU - Lawler M AU - Liu Q AU - McClure C AU - Mehmood A AU - Mitchell H AU - Morrison DS AU - Murray D AU - Norwood T AU - Phillips KAM AU - Ransom D AU - Shack L AU - Smits S AU - Saint-Jacques N AU - Marvelde LT AU - Tran D AU - Turner D AU - Ursin G AU - Vernon S AU - Walker MJ AU - Woods RR AU - Zhang B AU - Bray F AU - Soerjomataram I PY - 2026 JO - The Lancet. Oncology DO - 10.1016/s1470-2045(26)00089-6 UR - https://doi.org/10.1016/s1470-2045(26)00089-6 ER -
APA
E, M., A, B., O, L., MJ, R., HA, E., D, B., A, B., O, B., J, B., DA, C., K, C., K, C., A, C., N, C., P, D., S, E., D, F., MG, G., J, H., DW, H., CGCA, J., SM, K., E, K., S, L., M, L., Q, L., C, M., A, M., H, M., DS, M., D, M., T, N., KAM, P., D, R., L, S., S, S., N, S., LT, M., D, T., D, T., G, U., S, V., MJ, W., RR, W., B, Z., F, B., & I, S. (2026). International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study.. The Lancet. Oncology. https://doi.org/10.1016/s1470-2045(26)00089-6
Source records
- pubmed · retrieved 2026-09-26T18:54:03.402Z